Found 7 resultsAuthor Title Type [ Year]
Filters: First Letter Of Title is P and Author is Dally, L [Clear All Filters]
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults. PLoS One, 10, e0125954. presented at the 05/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25961283. (2015).
Phase 1 Safety and Immunogenicity Evaluation of ADVAX a Multigenic, DNA-Based Clade C/B’ HIV-1 Candidate Vaccine. PLoS ONE, 5, e8617. presented at the 01/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20111582. (2010).
A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant Adeno-Associated Virus HIV Vaccine. In AIDS Vaccine 2007 Conference. presented at the 20/08/2007, Seattle, WA. Retrieved from http://www.vaccineenterprise.org/conference_archive/2007/index.html. (2007).
Phase 2A Dose and Route Study of a DNA Prime MVA Boost Vaccine Candidate. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.. (2005).
Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial. AIDS, 12(14), 1851-9. presented at the 1998 Oct 01. doi:10.1097/00002030-199814000-00017. (1998).